Statins, widely recognized for their cholesterol-lowering effects by targeting HMG-CoA reductase, also significantly reduce the risk of heart attacks, acute heart failure, and mortality (Zhou and Liao, 2009; Bugiardini et al., 2022). The gene discussed is HMGCR; the disease is myocardial infarction.